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Regulation of prostaglandin E2 synthesis by angiotensin H, po-
tassium, osmolality, and dexamethasone. We investigated the reg-
ulation of cellular prostaglandin E2 (PGE2) biosynthesis in rabbit
renomedullary interstitial cells in tissue culture. Arachidonic
acid markedly stimulated PGE2 biosynthesis by these cells. Re-
peated exposure to arachidonic acid, however, resulted in pro-
gressively less stimulation of PGE2 biosynthesis. Potassium and
dexamethasone diminished PGE2 biosynthesis by decreasing the
rate of arachidonic acid release from the endogenous arachidonic
acid storage pool. Hyperosmolality, like angiotensin II, bradyki-
nm, and arginine vasopressin, stimulated PGE2 biosynthesis by
increasing the rate of arachidonic acid release. Inhibitors of pro-
tein synthesis diminished angiotensin II-, bradykinin-, and argi-
nine-vasopressin-stimulated PGE2 biosynthesis by decreasing
hormone-stimulated arachidonic acid release. The effects of po-
tassium, dexamethasone, arachidonic acid, and hyperosmolality
on PGE2 biosynthesis were unaffected by protein synthesis in-
hibitors. Hormone-stimulated phospholipase activation is depen-
dent on protein synthesis, whereas potassium, hyperosmolality,
and dexamethasone alter the release of arachidonic acid from
cellular lipids via a mechanism that is independent of protein
synthesis.
Regulation de Ia synthèse de prostaglandine E2 par I'angio-
tensine II, le potassium, l'osmolalité, et Ia dexaméthasone. Nous
Ctudions Ia regulation de Ia synthese cellulaire de prostaglan-
dine E2 (PGE2) dans des cultures de cellules interstitielles de
Ia médullaire rénale de lapin. L'acide arachidonique stimule de
facon importante Ia synthèse de PGE2 par ces cellules.
L'exposition répétée a l'acide arachidonique, cependant, a pour
consequence une diminution progressive de Ia stimulation de Ia
biosynthese de PGE2. Le potassium et Ia dexaméthasone dimin-
uent Ia biosynthése de PGE2 en diminuant le debit de liberation
de I'acide arachidonique a partir du pool endogène de stockage.
L'hyperosmolalité, de méme que l'angiotensine II, Ia bradyki-
nine, et l'arginine vasopressine, stimulent Ia synthèse de PGE2
en augmentant Ia liberation d'acide arachidonique. Les inhib-
iteurs de Ia synthèse protéique diminuent les stimulations par
l'angiotensine II. Ia bradykinine, et l'arginine vasopressine en di-
minuant Ia liberation d'acide arachidonique stimulée par ces hor-
mones. Les effets du potassium, de Ia dexaméthasone, de l'acide
arachidonique, et de l'hyperosmolalite sur Ia synthèse de PGE2
ne sont pas modifies par les inhibiteurs de Ia synthèse protéique.
L'activation de Ia phospholipase dépendante de Ia stimulation
hormonale est soumise a La synthèse protéique alors que le po-
tassium, I'hyperosmolalite, et Ia dexaméthasone modifient Ia lib-
ération d'acide arachidonique a partir des lipides cellulaires par
un mécanisme qui est indépendant de Ia synthèse protéique.
The prostaglandins play a major role in many as-
pects of normal and abnormal renal function [1].
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Within the kidney there are five cellular sites of
prostaglandin biosynthesis: the renomedullary in-
terstitial cells [2—5], the tubular epithelium of the
collecting duct [6, 7], the epithelial cells of Bow-
man's capsule, the glomerulus, and the vascular en-
dothelium [7]. The renomedullary interstitial cells
are characterized by lipid storage vacuoles [2—4],
which are rich in arachidonic acid, the precursor of
prostaglandin E2 (PGE2). Studies of the regulation
of in vivo PGE2 biosynthesis by the kidney are ham-
pered by the many interlocking regulatory mecha-
nisms that characterize renal function. To investi-
gate the regulation of PGE2 biosynthesis in a system
free of these interrelated physiologic mechanisms,
we have recently isolated and characterized the re-
nomedullary interstitial cell of the rabbit in tissue
culture [4]. Prostaglandin E2 biosynthesis by the re-
nomedullary interstitial cell is stimulated by arachi-
donic acid, angiotensin II (All), bradykinin, and ar-
ginine vasopressin [4]. The stimulation of PGE2 bio-
synthesis by vasoactive peptides is due to an
increase in arachidonic acid release via stimulation
of a cellular phospholipase [5]. Free arachidonic
acid is converted by an oxygenase to the prosta-
glandin endoperoxides, PGG2 and PGH2, and sub-
sequently to PGE2 by an isomerase and peroxidase
[8]. Hormone-stimulated prostaglandin biosyn-
thesis can be inhibited by mepacrine [9], a phos-
pholipase inhibitor, or by the nonsteroidal anti-
inflammatory agents, which inhibit the oxygenase
[5].
Although the hormonal stimulation of PGE2 bio-
synthesis via phospholipase activation is a mecha-
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nism common to a number of hormone-sensitive tis-
sues and cells [4, 5, 9—16], other substances may
stimulate or inhibit PGE2 biosynthesis by affecting
the availability of the precursor, arachidonic acid,
or the amount of active oxygenase. Recent studies
have shown that renal PGE2 biosynthesis is en-
hanced in man [17] and in the dog [18] with total
body potassium deficiency. Corticosteroids also
have been shown to inhibit hormone-stimulated
PGE biosynthesis by reducing arachidonic acid re-
lease via a mechanism thought to involve a stabili-
zation of the cellular membrane, which contains
arachidonic acid incorporated into phospholipids
[12, 16, 19—22]. Furthermore, arachidonic acid ox-
ygenase demonstrates a "self-destructive" charac-
teristic [23]; this property of the enzyme suggests
that the unlimited synthesis of prostaglandins will
not occur despite an unlimited availability of arachi-
donic acid.
The isolation of the rabbit renomedullary inter-
stitial cell in tissue culture provides a model system
for the study of the regulation of cellular pro staglan-
din E2 biosynthesis. The purpose of this study was
to study the role of protein synthesis and the effects
of potassium, osmolality, corticosteroids, and
arachidonic acid on PGE2 biosynthesis.
Methods
Rabbit renomedullary interstitial cells were
grown in monolayer tissue culture as previously de-
scribed. Trypsin-dispersed renal interstitial cells
were replicate-plated in 24-cup tissue culture plates
(Costar Cluster) in RPMI-1640 tissue culture medi-
um supplemented with fetal bovine serum, 4-(2-hy-
droxyethyl)-1-piperazine ethane sulfonic acid buf-
fer, glutamine, penicillin, and streptomycin [4].
Radioactively labeled renomedullary interstitial
cells were prepared by the addition of[5, 6, 8,9, 11,
12, 14, 15-3H(N)]-arachidonic acid (New England
Nuclear, 72 Ci/mmole) to the tissue culture medium
24 hours prior to each experiment.
Unlabeled or radioactively labeled renomedullary
cells were washed twice with saline (0.9% sodium
chloride solution) and incubated for 1 hour in a buf-
fered solution (pH, 8.1) containing 1.2 m magne-
sium sulfate, 1.3 m calcium chloride, 0.4 mi di-
sodium hydrogen phosphate, 22 m sodium chlo-
ride, 25 m sodium bicarbonate, 10 m glucose,
and 2 m reduced glutathione. Unless otherwise
indicated, the buffer also contained 3 m potas-
sium chloride and mannitol (quantum sufficit) to a
final osmolality of 300 mOsmlliter. After incubation
for 1 hour in a 95% air and 5% carbon dioxide atmo-
sphere, the buffered solution was removed, acid-
ified to a pH of 3.5, and extracted with 15 volumes
of chloroform. In experiments with unlabeled cells,
the solution was assayed for PGE2 by radioimmuno-
assay as previously described [4]. In studies with
cells incubated with tritium-labeled arachidonic
acid, the arachidonic acid, PGE2, and PGF2c, re-
leased into the medium were isolated by thin-layer
chromatography as previously described [5].
Effect ofpotassium and osmolality on PGE2 bio-
synthesis. The buffer composition described above
was modified to a potassium concentration of either
0 or 3 mEq/liter. The total osmolality of the buffered
solution was modified to a final osmolality of 300 or
1200 mOsm/liter as determined from the quantity of
mannitol added to the solution.
Effect of dexamethasone. The cells were incubat-
ed for 18 hours with dexamethasone (1 M) in
RPMI-1640 tissue culture medium. After the cells
had been washed with saline, dexamethasone (1
ILM) was added to the buffered solution described
above, and the cells were incubated for 1 hour at 370
C in a 95% air and 5% carbon dioxide atmosphere.
Effect of arachidonic acid. Arachidonic acid
(NuChekPrep), linoleic acid, or linolenic acid (Sig-
ma), 3 m, was solubilized in RPMI-1640 tissue
culture medium supplemented with 20% fetal calf
serum. After a control period, the cells were in-
cubated with the lipid-containing solution for three
successive 1-hour periods. The cells were washed,
and the medium was changed after each 1-hour in-
cubation period.
Effect of protein synthesis inhibition. Cyclo-
heximide (10 g/ml), actinomycin D (5 gIml), eme-
tin (2 sg/ml), 1-1-tosylamido-2-phenyl-chloro-
methane (TPCK, 30 g/ml), or N-n-tosyl-L-lysine
chloromethylketone (TLCK, Sigma, 20 g!ml)
were added to the incubation medium of the re-
nomedullary interstitial cells in tissue culture 2
hours prior to the beginning of the experiment. The
effect of protein synthesis inhibition on PGE2 bio-
synthesis stimulated by angiotensin II (All; Calbio-
chem; 2 x 10 M), bradykinin (Beckman; 5 x 10-8
M), and arginine vasopressin (supplied by Dr. J. S.
Handler, 7.5 X 10 M) was determined. The effect
of protein synthesis inhibition on PGE2 biosynthesis
was determined also under conditions of varied po-
tassium concentration, varied osmolality, and after
the addition of arachidonic acid.
Statistical analysis. Statistical comparisons were
made with Student's t test [24].
Results
Effect of potassium and os,nolality (Tables / and
2). Potassium (3 m) inhibited PGE2 biosynthesis,
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Experimental conditions
PGE2 biosynthesis
ng PGE2/pg
cellular protein/hr
Potassium
concentration
mEq/liter
Osmolality
mOsm/liter
0 300 0.86 0.05"
3 300 0.51 0.04
3 1200 214010b
Radiolabeled
Experimental conditions material released
cpm released/hr
Potassium
concentration Osmolality Arachidonic
mEq/liter mOsm/liter acid PGE2
0 300 7542 528" 1147 84b
3 300 4226 315 627 45
3 1200 16196 1168" 2536 157"
as compared with PGE2 biosynthesis by cells in-
cubated in potassium-free buffer at the same os-
molality (P <0.001) (Table 1). When tritium-la-
beled arachidonic acid had been incorporated into
the cellular lipids, and the lipids released during the
1-hour incubation period were analyzed by thin-lay-
er chromatography, we found that potassium (3 mM)
decreased arachidonic acid release (P < 0.001) but
had no effect on the ratio of PGE2 formed to the
arachidonic acid released (Table 2). A progressive
decrease in PGE2 synthesis was observed when the
potassium content of the incubation medium was in-
creased from 0 to 7 mEq/liter. The inhibition of
PGE2 synthesis by potassium was linear in the
1.2
0A4l1007X,2<X<7
0.2 r 0.97, P <0.01
range of potassium concentration from 2 to 7 mEq/
liter and could be represented by the equation Y =
0.74 (1 — 0.07x), where Y is the PGE2 synthesis,
and x is the potassium concentration (Fig. 1). Thus,
within this range of potassium concentration, the
rate of PGEZ synthesis inhibition was 7% per mEq/
liter increase in potassium concentration.
Hyperosmolality (1200 mOsm/liter) stimulated
PGE2 biosynthesis, as compared with PGE2 biosyn-
thesis by cells incubated at an osmolality of 300
mOsm/liter (P <0.001) (Table 1). Hyperosmolality
increased arachidonic acid release (P < 0.001), but
had no effect on the ratio of PGE2 formed to the
arachidonic acid released (Table 2).
Effect of dexamethasone (Table 3). Dexametha-
sone (1 LM) inhibited PGE2 biosynthesis, as com-
pared with PGE2 biosynthesis by cells not exposed
to the steroid (P < 0.001). Dexamethasone in-
hibited arachidonic acid release ( P < 0.001) but
had no effect on the ratio of PGE2 formed to the
arachidonic acid released. Corticosteroids have
been reported to prevent prostaglandin release
without inhibiting prostaglandin biosynthesis in
some tissues [19, 22]. If the interstitial cells were
scraped from the plate, no PGE2 was found within
either the dexamethasone-treated or the control
cells, as was our finding in previous experiments
[4].
Effects of arachidonic acid (Table 4). Arachidon-
ic acid (3 mM) increased PGE2 biosynthesis to 112
Table 1. Effect of potassium and osmolality on PGE2
biosynthesis by rabbit renomedullary interstitial cells in tissue
culturea
a Rabbit renomedullary interstitial cells were incubated at
37°C for 1 hour in a buffered solution (pH, 8.1) containing 1.2mM
magnesium sulfate, 1.3 m calcium chloride, 0.4 mrt disodium
hydrogen phosphate, 22 m sodium chloride, 25 mM sodium bi-
carbonate, 10 m glucose, and 2 m reduced glutathione. Potas-
sium chloride (3 mEq/liter) was added as indicated. The os-
molality of the buffered solution was adjusted by the addition of
mannitol. Each value represents the mean SEM (N = 8).
"p <0.001 compared with PGE2 biosynthesis under the ex-
perimental conditions of 3 mEq/liter potassium and 300 mOsm/
liter osmolality.
Table 2. Effect of potassium and osmolality on arachidonic acid
release and PGE2 biosynthesis by rabbit renomedullary
interstitial cells in tissue culturea
0 1 2 3 4 5 6 7
Potassium concentration, mEq/Iiter
Fig. 1. Effect of potassium on PGE2 synthesis by rabbit renome-
dullary interstitial cells in tissue culture. The potassium concen-
tration of the incubation medium was increased by addition of
potassium chloride to the buffered solution. In the range of po-
tassium concentration from 2 to 7 mEq/liter, the rate of PGE2
synthesis was inhibited in a linear fashion by increasing potas-
sium concentration and could be expressed by the equation Y =
0.74 (1 — 0.7x), regression analysis correlation coefficient =
0.97, P < 0.01. Each value represents the mean SEM (N = 4).
a The cellular lipids of rabbit renomedullary interstitial cells
in tissue culture were labeled by incubation with [5,6,8,9,11,
12,14, 15-3H(N)]-arachidonic acid. The arachidonic acid, PGE2,
and PGE released into the medium were isolated by thin-layer
chromatography. The values for the radiolabeled materials re-
leased represent the means SEM (N = 8).
"P < 0.001 compared with radiolabeled arachidonic acid and
PGE2 released under the experimental conditions of 3 mEq/liter
potassium and 300 mOsni/liter osmolality.
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6 ng/g of cellular protein per hour. Repeated
arachidonic acid stimulation, however, resulted in
significantly less PGE2 biosynthesis than the PGE2
biosynthesis observed after the initial exposure to
arachidonic acid. If the cells were incubated for 2
hours with linoleic acid or linolenic acid, polyenoic
octadecanoic fatty acids that are not precursors for
prostaglandin synthesis, and only exposed to
arachidonic acid during the third hour of in-
cubation, PGE2 synthesis was, respectively, 107
8 and 103 12 ngJpg of cellular protein per hour
during the third hour of incubation. No light-micro-
scopic evidence of damage to the cells was noted
after incubation with arachidonic acid.
Effect of protein synthesis inhibition (Tables 5
and 6). Cycloheximide (10 .tgIml) inhibited the
PGE2 biosynthesis stimulated by All, bradykinin,
and vasopressin. Cycloheximide did not inhibit the
effects of hyperosmolality, arachidonic acid, dexa-
Table 3. Effect of dexamethasone on POE2 biosynthesis and
arachidonic acid release by rabbit renomedullary interstitial cells
in tissue culturea
Dexamethasone-
Control treated
POE2 biosynthesis, ng
PGE2Ipg cellular protein/hr 0.73 0.12 0.16 0.04"
Radiolabeled material released,
cpm released/hr
Arachidonic acid 4936 393 912 I 14"
POE2 805 142 162 36"
PGF,,, 128 26 26 4"
aUfliabeled or radiolabeled rabbit renomedullary interstitial
cells were incubated for 18 hours with 1 tM dexamethasone. Af-
ter being washed, control and dexamethasone-treated cells were
incubated for 1 hour at 37°C in a 95% air and 5% carbon dioxide
atmosphere. POE2 biosynthesis by unlabeled cells was deter-
mined by radioimmunoassay. Radiolabeled lipids released were
isolated by thin-layer chromatography. Each value represents
the mean SaM (N = 8).
"P < 0.001 compared with controI" values.
methasone, or potassium on PGE2 biosynthesis
(Table 5). The effect of cycloheximide on the PGE2
biosynthesis stimulated by All, bradykinin, and
vasopressin resulted from the inhibition of hor-
mone-stimulated arachidonic acid release (Table
6). The effect of cycloheximide on All-stimulated
PGE2 biosynthesis cannot be explained on the basis
of decreased binding of All to its cellular receptor,
because cycloheximide does not alter the binding of
All to these cells [25]. The effects of actinomycin
D, emetin, TPCK, and TLCK were similar to the
effect of cycloheximide (data not shown).
Discussion
The regulation of PGE2 biosynthesis by the rabbit
renomedullary interstitial cell in tissue culture is
characterized by the complex interaction of a num-
ber of polypeptides and other factors (Fig. 2). Angi-
otensin II, bradykinin, and arginine vasopressin
stimulate PGE2 biosynthesis by the renomedullary
interstitial cell. These vasoactive peptides increase
the release of arachidonic acid from the cellular
storage pool, primarily phospholipids, via increased
Table 4. Effect of arachidonic acid on PGE2 biosynthesis by
rabbit renomedullary interstitial cells in tissue culturea
Experimental conditions
POE2 biosynthesis
ng PGE2/p.g cellular protein/hr
Control 0.66 0.14
Arachidonic acid,
Otolhr 112±6.1
Ito2hr 43±3.2
2to3hr 10± 1.7
a Rabbit renomedullary interstitial cells were incubated in
RPMI-1640 tissue culture medium supplemented with 20% fetal
calf serum in the absence of exogenous arachidonic acid (con-
trol). Arachidonic acid (3 mM) was added for the next three 1-
hour periods, and PGE2 biosynthesis was measured by radioim-
munoassay. Each value represented the mean SEM (N =8).
Table 5. Effect of cycloheximide on POE2 biosynthesis by rabbit renomedullary interstitial cells in tissue culture°
POE2 biosynthesis
.
Experimental conditions
or agents added
ng PGE21 ,sg cellularprotein/hr
Control Cycloheximide-treated
Basal 0.62 0.13 0.66 0.19
Angiotensin II (2 X 10°M) 9.18 0.49 2.94 0.37"
Bradykinin(5 X l08s) 3.19 0.29 1.18 0.27"
Arginine vasopressin (7.5 X l0 M) 2.52 0.23 0.96 0.22"
Potassium (0 mEq/liter) 1.10 0.16 1.05 0.23
Hyperosmolality (1200 mOsni/liter) 2.68 0.25 2.81 0.41
Arachidonic acid (3 mM) 106 15 102 17
Dexamethasone (0.5 ILM) 0.34 0.08 0.30 0.05
a Cycloheximide (10 g/ml) was added 2 hours prior to the beginning of the experiment. Prostaglandin E2 biosynthesis was measured
by radioimmunoassay. Each value represents the mean SEM (N = 6).
b P < 0.01.
Cycloheximide—— -
phospholipase activity [26]. PGE2 biosynthesis
stimulated by All, bradykinin, and vasopressin can
be inhibited by mepacrine, a phospholipase inhib-
itor [5]. The activation of phospholipase by poly-
peptide hormones is a mechanism common to many
cellular [4, 5, 11—13] and in vitro organ systems [9,
10, 14-16]. Pong, Hong, and Levine [13] have re-
ported that cycloheximide, a protein synthesis in-
hibitor, prevents hormone-stimulated PGE2 biosyn-
thesis in the BALB/3T3 mouse fibroblast in tissue
culture and suggested that hormonal stimulation of
PGE2 biosynthesis is dependent on synthesis of an
"unstable" protein regulating the availability of
arachidonic acid. The results of our own experi-
ments are consistent with such a mechanism and
identify a decrease in arachidonic acid release as
the mechanism of cycloheximide inhibition of hor-
mone-stimulated PGE2 biosynthesis in the reno-
medullary interstitial cell [26].
Urinary PGE excretion, which is a measure of
renal prostaglandin biosynthesis, is increased in
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Bartter's syndrome, a clinical disorder character-
ized by total body potassium depletion [17]. Galvez
et al have reported increased urinary PGE excretion
in potassium-depleted, hemodialyzed dogs [18].
The inhibition of PGEZ biosynthesis by potassium in
the renomedullary interstitial cell is consistent with
these in vivo observations. The effect of potassium,
hyperosmolality, and dexamethasone are not de-
pendent on protein synthesis, in contrast to the ef-
fects of All, bradykinin, and arginine vasopressin.
The failure of cycloheximide to alter the effects of
potassium, hyperosmolality, or dexamethasone on
PGE2 biosynthesis suggests to us that potassium,
hyperosmolality, and dexamethasone do not affect
phospholipase activity, but rather alter the avail-
ability of cellular phospholipids to the phospholi-
pase.
Although the availability of arachidonic acid ap-
pears to be the primary regulatory step in PGE2 bio-
synthesis by the rabbit renomedullary interstitial
cell, the self-destructive properties of the cy-
Table 6. Effect of cycloheximide on arachidonic acid release and PGE2 biosynthesis stimulated by AH. bradykinin. and arginine
vasopressina
Agents added
Radiolabeled materials reteased. cprn released/hr
Arachidonic acid PGE2
Control 3612 222 476 76
ALl 247172 8714 39755 4026
+ cycloheximide 83490 286Ob 13478 1482"
Bradykinin 110733 4861 18363 2012
+ cyloheximide 35166 2012" 5626 624"
Arginine vasopressin 97639 3722 16224 1966
+ cycloheximide 29128 1%3b 4899 586b
a The cellular lipids of rabbit renomedullary interstitial cells in tissue culture were labeled by incubation with [5,6,8,9,11,12,14,15
3H(N)]-arachidonic acid. Cycloheximide (10 sg/ml) was added 2 hours prior to the beginning of the experiment. The renomedullary
interstitial cells were incubated for 1 hour with All (2 x l0— M), bradykinin (5 X 10—8 M), or arginine vasopressin (7.5 X l0 M). The
arachidonic acid, and PGE2 released into the incubation medium were isolated by thin layer chromatography. Values represent the
means SEM (N = 8).
"P < 0.001 compared with arachidonic acid and PGE2 release after incubation with the polypeptide hormone alone.
Arachidonic
acid —
storage pool
Mepacri ne
Acyihydrolase
(phospholipase)
Angiotensin 11
Bradykinin
Arginine vasopressin
Potassium Corticosteroids
I I
I I Free arachidonic acid
'1
Hyperosmolality
Non-steroidal
—Oxygenase
anti-inflammatory agents"
+
________________Prostaglandin endoperoxidesProstaglandin E2 (PGG2, PGH2)
Fig. 2. Regulation of PGE2 biosynthesis by the rabbit reno'nedullarv interstitial cell in tissue culture.
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clooxygenase may play a role. Egan, Paxton, and
Kuehi have shown that the generation of oxidizing
equivalents during PGE2 biosynthesis results in the
destruction of the cyclooxygenase and that free rad-
ical scavengers will prevent the destruction of the
enzyme [23]. The decreased PGE2 biosynthesis ob-
served after repeated arachidonic acid exposure
may represent the destruction of cyclooxygenase
activity by the free-radical intermediates of the
prostaglandin synthesis pathway. It is also possible
that in the course of the incubation with arachidonic
acid for 3 hours, depletion of endogenous reducing
agents, which scavenge oxygen free-radicals pro-
duced during PGE2 biosynthesis, occurred. We
consider this to be an unlikely explanation for the
results obtained because freshly prepared buffers
containing 20% fetal calf serum were added each
hour.
The concentration of arachidonic acid (3 mM)
used in this study was considerably higher than the
concentration (0.02 mM) required to inactivate
platelet cyclooxygenase [27]. The increased con-
centration and length of exposure to arachidonic
acid required to inactivate the cyclooxygenase of
the rabbit renomedullary interstitial cell may be due
to the ability of this cell type to synthesize protein
and thus replenish the cellular cyclooxygenase. In
contrast, the platelet is incapable of protein syn-
thesis, and therefore cannot replenish the cy-
clooxygenase activity. Thus, the concentration and
duration of exposure to arachidonic acid must be
greater in the tissue capable of protein synthesis.
Because of the high concentration of arachidonic
acid required to inactivate the cyclooxygenase of
the renomedullary interstitial cell in vitro, the phys-
iologic significance of this phenomenon in these
cells in vivo remains unknown. This study demon-
strates, however, that the inactivation of the cy-
clooxygenase can occur in an intact cell in tissue
culture.
The isolation of rabbit renomedullary interstitial
cells in tissue culture has provided a model system
for the study of the regulation of cellular PGE2 bio-
synthesis. Using this model, we have found that
All, bradykinin, and vasopressin stimulate PGE2
biosynthesis via increased arachidonic acid release
after phospholipase activation. The activation of
phospholipase by polypeptide hormones is depen-
dent on protein synthesis, whereas the active phos-
pholipase can be inhibited by mepacrine. In con-
trast to the polypeptide hormones, hyperosmolality
stimulated PGE2 biosynthesis via a mechanism that
results in increased arachidonic acid release but is
not dependent on protein synthesis. These studies
further clarify the effects of hyperosmolality on re-
nal PGE2 biosynthesis. Danon et al recently report-
ed that hyperosmolality stimulated prostaglandin
biosynthesis in renal papillary slices. They sug-
gested that the stimulation of PGE2 synthesis was
secondary to an increase in arachidonic acid release
elicited by hypertonic saline [28]. The use of re-
nomedullary cells in tissue culture has confirmed
this proposed mechanism of stimulating PG biosyn-
thesis. Potassium and dexamethasone inhibit PGE2
biosynthesis by reducing arachidonic acid release.
Because the actions of potassium, dexamethasone,
and hyperosmolality are independent of protein
synthesis, they may affect the availability of cellular
lipids, primarily in the cell membrane, to phospholi-
pase action.
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